An apparatus for predicting urothelial carcinoma and a storage medium

CN121896357BActive Publication Date: 2026-08-28GENETRON HEALTH (BEIJING) CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610100049.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2026-01-26
Publication Date
2026-08-28
Estimated Expiration
2046-01-26

AI Technical Summary

Technical Problem

然而,现有的分子检测方法仍存在一些问题

Benefits of technology

[0019]本发明实施例提供的技术方案带来的有益效果包括:

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121896357B_ABST
    Figure CN121896357B_ABST
Patent Text Reader

Abstract

The application provides a device and a storage medium for predicting urothelial carcinoma, and belongs to the technical field of gene detection, and comprises: a sample acquisition module for acquiring genomic DNA of urinary sediment cells of a subject; a CNV detection module for performing low-depth whole genome sequencing and data analysis on the urinary sediment DNA to obtain a CNV detection result; a methylation detection module for performing methylation detection on specific genes when the CNV detection result is positive to obtain a methylation detection result; and a risk assessment module for determining a risk grade based on the CNV detection result and the specific gene methylation detection result. By integrating the advantages of various molecular markers, hierarchical assessment is realized, thereby improving the accuracy of risk assessment, reducing the false positive rate, providing risk early warning for early-stage low-grade patients, and at the same time, cost-effectiveness is taken into account, and a more reliable basis is provided for individualized treatment of urothelial carcinoma.
Need to check novelty before this filing date? Find Prior Art